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Abstract
Background: The present study was designed to (1) establish current sedation practice in UK critical care to inform
evidence synthesis and potential future primary research and (2) to compare practice reported via a survey with
actual practice assessed in a point prevalence study (PPS).
Methods: UK adult general critical care units were invited to participate in a survey of current sedation practice,
and a representative sample of units was invited to participate in a PPS of sedation practice at the patient level.
Survey responses were compared with PPS data where both were available.
Results: Survey responses were received from 214 (91 %) of 235 eligible critical care units. Of these respondents,
57 % reported having a written sedation protocol, 94 % having a policy of daily sedation holds and 94 % using a
sedation scale to assess depth of sedation. In the PPS, across units reporting a policy of daily sedation holds, a
median of 50 % (IQR 33–75 %) of sedated patients were considered for a sedation hold. A median of 88 %
(IQR 63–100 %) of patients were assessed using the same sedation scale as reported in the survey. Both the
survey and the PPS indicated propofol as the preferred sedative and alfentanil, fentanyl and morphine as the
preferred analgesics. In most of the PPS units, all patients had received the unit’s reported first-choice sedative (median
across units 100 %, IQR 64–100 %), and a median of 80 % (IQR 67–100 %) of patients had received the unit’s reported
first-choice analgesic. Most units (83 %) reported in the survey that sedatives are usually administered in combination
with analgesics. Across units that participated in the PPS, 69 % of patients had received a combination of
agents – most frequently propofol combined with either alfentanil or fentanyl.
Conclusions: Clinical practice reported in the national survey did not accurately reflect actual clinical practice
at the patient level observed in the PPS. Employing a mixed methods approach provided a more complete
picture of sedation practice in terms of breadth and depth of information.
Keywords: Sedation, Analgesia, Survey, Point prevalence, Critical care
Background
Sedation and analgesia are frequently administered to
patients in critical care units to facilitate therapies, such
as mechanical ventilation and other invasive procedures,
with the objectives of ensuring patient safety, comfort
and sometimes amnesia. Commonly used sedatives are
propofol, benzodiazepines and alpha-2 agonists (clonidine
and dexmedetomidine). Guidelines favour sedation strat-
egies using agents such as propofol or dexmedetomidine
over strategies using benzodiazepines to improve clinical
outcomes in mechanically ventilated patients [1]. Previous
surveys conducted in the United Kingdom (UK) [2, 3]
and elsewhere [4] indicate a shift away from benzodi-
azepines toward propofol for sedating patients in crit-
ical care. Guidelines on sedation also include
recommendations for pain management, with an em-
phasis on assessing and treating pain first before ad-
ministering sedative medication [1].
The Intensive Care National Audit & Research Centre
(ICNARC) was commissioned by the National Institute
for Health Research Health Technology Assessment
Programme to design and conduct a study to establish
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current sedation practice in UK adult critical care. The
overall aim of the study was to provide baseline data on
current practice to inform evidence synthesis and poten-
tial future primary research. Specific objectives were to
establish (1) through a survey of all UK adult general
critical care units, reported current sedation practice;
and (2) through a point prevalence study (PPS) in a rep-
resentative sample of UK adult general critical care
units, the current prevalence of use of sedative agents
and regimens. This combination of study designs was se-
lected to give the most complete picture of current prac-
tice in terms of both the breadth and the depth of
information and to examine reported versus actual clin-
ical practice.
Methods
National survey
National Health Service (NHS) adult general critical care
units were identified from databases maintained by
ICNARC, and the Scottish Intensive Care Society Audit
Group [5]. A general critical care unit was defined as an
intensive care unit (ICU) or combined ICU-high-de-
pendency unit (HDU). Stand-alone HDUs and speciality
units (e.g., neurosciences, cardiothoracic) were excluded.
A review of previous surveys [2, 3, 6–10] informed de-
velopment of the survey tool (Additional file 1: Figure S1),
which captured information on management of sedation
as well as the use of specific sedative and analgesic agents.
With respect to analgesia, the focus was on analgesic
agents with a sedative effect, such as intravenous opioids,
rather than on oral or regional analgesia. Following pilot-
ing, the survey was sent via email, in January 2014, to the
clinical directors of all UK adult general critical care units,
who were asked to complete the survey either online
(via SurveyMonkey®), electronically or on paper. Non-
responders were followed up, with a second email
and then a telephone call, until May 2014.
Point prevalence study
The PPS was nested in the Case Mix Programme
(CMP), the national comparative clinical audit for adult
critical care in England, Wales and Northern Ireland,
coordinated by ICNARC. At the time, 95 % of all
possible adult general critical care units were participating
in the CMP.
It was estimated that a sample size of 50 units would
be required to give representation in terms of unit char-
acteristics and to allow for variation in sedation practice.
Based on CMP data, the mean number of patients in an
average-sized unit at 1400 on a midweek day is 9; there-
fore, the projected total sample size was 450 patients, of
whom it was anticipated that approximately 45 % (200
patients) would be sedated. Because the aim was to re-
cruit 50 units, the invitation to take part was restricted
to 97 actively participating units that were the most up-
to-date with data submission and validation at the time.
Those that agreed to take part were asked to complete a
short data collection form (Additional file 2: Figure S2)
for every patient in the unit at 1400 on 11 December
2013. For sedated patients (i.e., those who had received a
sedative and/or analgesic in the previous 24 h), staff
were asked to provide information on management of
sedation as well as sedative and/or analgesic agents re-
ceived. Completed data collection forms were returned
either electronically or on paper.
Statistical analysis
For the analyses, we used data from the CMP database,
which contains pooled case mix and outcome data on
consecutive admissions to participating units and has
been independently assessed to be of high quality [11].
Responses to categorical questions in the survey were
summarised as the number (percentage) of respondents
selecting each response. Continuous data were sum-
marised as the mean, SD and range (minimum to max-
imum) across the responses.
Patients in the PPS were compared with all patients in
CMP adult general critical care units at 1400 on 11 De-
cember 2013 for case mix, outcome and length of stay.
Numbers (percentages) of sedated patients assessed
using a sedation scale/score were summarised in
addition to, among patients who had been in the unit
for at least 24 h, those considered for and/or receiving a
sedation hold during the previous 24 h. The number
(percentage) of patients receiving each sedative and anal-
gesic and combinations of agents during the previous
24 h were summarised together with, for agents received
by five or more patients, the mean (SD) of the highest
rate of infusion (in milligrams per hour) and the total
dose (in milligrams), including both infusions and bo-
luses. With respect to analgesia, analgesia administered
orally or regionally (e.g., epidural) was excluded from
the analysis.
Survey responses were compared with PPS data, where
both were available, to investigate the degree to which
reported practice reflected actual practice. For units that
reported daily sedation holds, the number (percentage)
of sedated patients who had been in the unit for at least
24 h and who had been considered for a sedation hold
was summarised. Across all units, the median proportion
and IQR of sedated patients considered for a sedation
hold were calculated.
For each sedation scale/score reported, the number
(percentage) of sedated patients in the PPS who were
assessed using the reported scale/score was summarised.
The median (IQR) proportion of patients assessed using
the same sedation scale/score as reported was calculated
across all units. For patients who had received a sedative
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agent, the proportion that received the unit’s reported
first-choice agent was summarised. The median (IQR)
proportion of patients receiving any sedative agent who
received the reported first-choice agent was calculated
across all units. The same approach was repeated for an-
algesic agents.
All data analyses were conducted using Stata/SE ver-
sion 13.0 software (StataCorp LP, College Station, TX,
USA). Support for the collection and use of patient-
identifiable data without consent for the CMP was ob-
tained under section 251 of the NHS Act 2006 (approval
PIAG 2-10(f )/2005).
Results
National survey
Of 235 eligible NHS adult general critical care units,
completed surveys were received from 214 (91.1 %). Re-
sponse rates were similar across different countries
(apart from Wales, in which the response rate was
lower), hospital types, unit sizes and participation or not
in the CMP (Additional file 3: Table S1). The majority of
survey responses were from the clinical director/lead
clinician (40.2 %) or another medical consultant in the
unit (31.3 %).
More than half (n = 122, 57.0 %) of units reported hav-
ing a written sedation or sedation/analgesia protocol. Of
these, 26 units (23.0 %) reported that compliance was
routinely audited; the approximate level of compliance
reported was a mean of 65 % (SD 20 %, range 26–100 %).
Almost all units (93.9 %) reported routinely using a
sedation scale/score to assess the depth of sedation
(Additional file 4: Table S2). Of these, approximately
two-thirds (64.7 %) reported using the Richmond
Agitation-Sedation Scale (RASS) [12] and a quarter
(24.9 %) reported using the Ramsay Sedation Scale
(RSS) [13]. Similarly, almost all units (93.9 %) reported
that a sedation hold was considered daily for patients. Of
these, 95 (47.3 %) units reported routinely auditing com-
pliance; the approximate level of compliance reported was
a mean of 82 % (SD 18 %, range 30–100 %) across the 89
units that provided this information. Of the 149 units
(69.6 %) that reported daily screening for delirium, almost
all (93.3 %) reported using the Confusion Assessment
Method for the Intensive Care Unit (CAM-ICU) [14].
Propofol was the most popular sedative agent; 98.1 %
of units reported very frequent/frequent use (Table 1).
Around one-third (32.2 %) of units reported very frequent/
frequent use of midazolam. Of the alpha-2 agonists, very
Table 1 National survey: sedative agents, analgesic agents, sedative/analgesic delivery regimens and their reported frequency of use
Reported frequency of use, n (%)
Very frequently/frequently Occasionally/rarely Never Not reported
Sedative agent
Propofol 210 (98.1) 2 (0.9) 0 (0) 2 (0.9)
Midazolam 69 (32.2) 130 (60.7) 11 (5.1) 4 (1.9)
Diazepam 4 (1.9) 96 (44.9) 105 (49.1) 9 (4.2)
Lorazepam 2 (0.9) 120 (56.1) 83 (38.8) 9 (4.2)
Clonidine 70 (32.7) 129 (60.3) 8 (3.7) 7 (3.3)
Dexmedetomidine 22 (10.3) 57 (26.6) 127 (59.3) 8 (3.7)
Haloperidol 79 (36.9) 115 (53.7) 13 (6.1) 7 (3.3)
Atypical anti-psychotica 15 (7.0) 94 (43.9) 89 (41.6) 16 (7.5)
Other 26 (12.1) 12 (5.6) – 176 (82.2)
Analgesic agent
Morphine 90 (42.1) 114 (53.3) 6 (2.8) 4 (1.9)
Fentanyl 77 (36.0) 89 (41.6) 41 (19.2) 7 (3.3)
Alfentanil 110 (51.4) 53 (24.8) 46 (21.5) 5 (2.3)
Remifentanil 72 (33.6) 106 (49.5) 32 (15.0) 4 (1.9)
Ketamine 1 (0.5) 177 (82.7) 28 (13.1) 8 (3.7)
Other 3 (1.4) 9 (4.2) – 202 (94.4)
Sedative/analgesic delivery regimen
Single sedative agent 47 (22.0) 142 (66.4) 4 (1.9) 21 (9.8)
Sedative(s) in combination with one or more analgesic agents 207 (96.7) 4 (1.9) 0 (0) 3 (1.4)
Multiple sedatives together 23 (10.8) 163 (76.2) 5 (2.3) 23 (10.7)
a For sedative purposes only
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frequent/frequent use of clonidine was reported by 32.7 %
of units, compared with 10.3 % for use of dexmedetomi-
dine. A high percentage of units (88.3 %) reported that pro-
pofol was generally their first choice of sedative agent,
compared with only 6.1 % reporting midazolam (three units
reported both agents) (Additional file 5: Table S3).
Alfentanil and morphine were the most popular anal-
gesic agents; 51.5 % and 42.1 % of units, respectively, re-
ported very frequent/frequent use (Table 1). Most units
(39.7 %) reported that generally alfentanil was their first
choice of analgesic agent, with around one-fourth
(26.2 %) reporting fentanyl (Additional file 6: Table S4).
Nearly all units (96.7 %) reported that they very fre-
quently/frequently deliver sedative(s) in combination
with analgesic(s) (Table 1), with the majority (82.7 %)
reporting this to be their first choice for delivery of seda-
tive and analgesic regimens (Additional file 7: Table S5).
Although cost was reported by nearly half (47.7 %) of
units as very important/important in determining the
choice of sedative and/or analgesic agent, 82.2 % of units
reported that the expected duration of sedation/anal-
gesia was very important/important (Additional file 8:
Table S6).
Point prevalence study
Fifty-two units participated, and validated CMP data
were available for 516 patients in 50 units. In addition,
validated CMP data were available for 1296 patients in 133
non-participating CMP units on the day of the study. In
general, unit characteristics (Additional file 9: Table S7) and
the case mix and outcomes of patients (Additional file 10:
Table S8, Additional file 11: Table S9) were similar for
participating and non-participating PPS units.
Fifty-one units participated in both the PPS and the
national survey. Sedation practices reported by these
units were similar to sedation practices reported by the
163 units that participated in the national survey only
(Additional file 12: Table S10, Additional file 13: Table
S11, Additional file 14: Table S12, Additional file 15:
Table S13, Additional file 16: Table S14).
Of the 550 patients in the 52 participating units on the
study day, a completed data collection form was
returned for 541 patients (98.4 %), 242 (44.7 %) of whom
had been sedated during the previous 24 h. Of the 541
patients with a completed data collection form, validated
CMP data were available for 516 patients (95.4 %) (n =
230 sedated patients), enabling comparison of character-
istics and outcomes of sedated and non-sedated patients.
Sedated patients were slightly younger than non-sedated
patients (mean age 59.3 years versus 63.6 years) but
similar in terms of gender, ethnicity and severe co-
morbidities (Additional file 17: Table S15). Sedated pa-
tients had higher acute severity of illness and were more
likely to have been mechanically ventilated (78.4 % versus
43.7 %) during the first 24 h in the unit, and had, on aver-
age, been in the unit for a shorter time at the point of the
study (mean 6.9 days versus 10.6 days). On the day of the
study, 12.0 % (n = 29) of the sedated patients were being
ventilated via a tracheostomy.
Of the 242 sedated patients in the 52 participating
units, 34 (14.0 %) had received only sedatives, 42
(17.4 %) only analgesics and 166 (68.6 %) both sedative
and analgesic agents. A sedation scale/score was re-
corded for 222 patients (91.7 %). Of these, two-thirds
(66.7 %) were assessed using the RASS [12], with the
remaining patients assessed using the RSS [13] (20.3 %)
or other scales (13.1 %). Of patients eligible for a sed-
ation hold (n = 186), 100 (53.8 %) had been assessed,
and 77 (77.0 %) had received a sedation hold during
the previous 24 h.
The most frequently used sedative was propofol, re-
ceived by over two-thirds (71.9 %) of patients during the
previous 24 h, with midazolam and clonidine received
by 21 (8.7 %) and 20 (8.3 %) patients, respectively
(Table 2). Use of analgesic agents was more variable;
alfentanil and fentanyl were the most frequently used
agents (31.4 % and 27.3 %, respectively). The most com-
mon combinations of sedative and analgesic agents were
propofol combined with either alfentanil (n = 49, 20.3 %)
or fentanyl (n = 44, 18.2 %) (Table 3). In isolation,
propofol was the most frequently used sedative (n =
15, 6.2 %) and morphine the most frequently used
analgesic (n = 22, 9.1 %).
Comparison of reported versus actual practice
In units that reported in the national survey that a sed-
ation hold is considered daily for patients, just over half
(n = 97, 53.0 %) of eligible patients in the PPS had been
considered for a sedation hold in the previous 24 h.
Across units, the median percentage of patients who
had been considered for a sedation hold was 50 %
(IQR 33–75 %).
Across units, a median of 88 % (IQR 63–100 %) of pa-
tients were assessed using the same sedation scale/score
as reported (Table 4). Two units that reported using the
RSS [13] had assessed the majority of patients in the
PPS using the RASS [12], and two units that reported
using the RASS had assessed the majority of patients
using the RSS, suggesting possible confusion between
these scales with similar names.
In units that reported propofol as their first-choice
sedative, the majority (87.6 %) of sedated patients had
received propofol (Table 5). However, in units that indi-
cated midazolam as their first choice, only one-third
(33.3 %) of patients had received midazolam. Actual use
of the reported first-choice analgesic varied from 93.4 %
among patients in units that had reported fentanyl as
their first choice to 53.4 % among patients in units that
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had reported morphine as their first choice. Across
units, a median of 80 % (IQR 67–100 %) of patients re-
ceived the unit’s reported first-choice analgesic.
Discussion
Of the 235 UK NHS adult general critical care units
identified, a high proportion (91.1 %) responded to the
survey. In addition, a representative sample of 52 units
also participated in the PPS. Data derived from the two
studies indicated that reported practice does not neces-
sarily reflect actual practice. Most (88 %) PPS patients
were assessed using the same sedation scale/score re-
ported in the survey; however, there was some variation
across units. Furthermore, although a high proportion
(94 %) of units reported using daily sedation holds, over-
all only half of sedated patients in the PPS who had been
in the unit for 24 h or more had been considered for a
sedation hold during the previous 24 h.
Both the survey and PPS indicated that propofol is the
preferred sedative and alfentanil, fentanyl and morphine
the preferred analgesics in UK critical care. Most units
(83 %) reported frequently/very frequently administering
sedatives in combination with analgesics, and around
two-thirds (68.6 %) of patients in the PPS had received a
combination of sedatives and analgesics, most frequently
propofol combined with either alfentanil or fentanyl.
The use of guidelines or protocols for management of
pain, agitation and delirium is strongly recommended
[1, 15]. Only 57 % of units reported having a written
sedation protocol, similar to the findings of a recent
Table 2 Point prevalence study: sedative and analgesic agents received
Received Highest rate of infusion (mg/h) Total dose (mg)
n (%) Reported, n Mean (SD)a Reported, n Mean (SD)a
Sedative agent
Propofol 174 (71.9) 162 138 (87) 172 2052 (1734)
Haloperidol 8 (3.3) 1 – 8 6.6 (3.8)
Midazolam 21 (8.7) 16 7.1 (4.8) 21 97.2 (121.5)
Clonidine 20 (8.3) 9 0.17 (0.18) 18 1.3 (1.9)
Dexmedetomidine 4 (1.7) 3 – 3 –
Ketamine 1 (0.4) 1 – 1 –
Diazepam 4 (1.7) 0 – 4 –
Lorazepam 3 (1.2) 0 – 2 –
Olanzapine 2 (0.8) 0 – 1 –
Thiopentone 2 (0.8) 0 – 2 –
Analgesic agent
Alfentanil 76 (31.4) 74 2.3 (1.9) 76 40.9 (36.6)
Fentanyl 66 (27.3) 59 0.15 (0.21) 59 1.7 (1.5)
Remifentanil 24 (9.9) 22 0.57 (0.63) 21 9.3 (9.6)
Morphine 48 (19.8) 20 4.3 (4.5) 46 57.8 (83.8)
a Included only if reported for at least five patients
Table 3 Point prevalence study: most frequent combinations of
sedative and analgesic agents and single sedative/analgesic
agents
Sedative/analgesic agents n (%)
Most frequenta combinations of sedative and analgesicb agents
Propofol and alfentanil 49 (20.3)
Propofol and fentanyl 44 (18.2)
Propofol and remifentanil 12 (5.0)
Propofol and morphine 10 (4.1)
Propofol, midazolam and alfentanil 4 (1.7)
Propofol, midazolam and fentanyl 4 (1.7)
Propofol, clonidine and alfentanil 3 (1.2)
Most frequenta single sedative agents
Propofol 15 (6.2)
Clonidine 5 (2.1)
Most frequenta single analgesicb agents
Morphine 22 (9.1)
Fentanyl 8 (3.3)
Alfentanil 5 (2.1)
Remifentanil 4 (1.7)
a Combinations/single agents included only if reported for at least
three patients
b With or without additional paracetamol, codeine or bupivacaine
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Internet-based survey of UK critical care pharmacists
in which 55 % of respondents reported use of sedation
guidelines [16]. However, this is considerably lower than
previously reported in the United Kingdom. In a tele-
phone survey conducted in 2011 [17] and a postal survey
[3] conducted in 2007, 82 % of units reported having a
written sedation policy and 80 % having a sedation guide-
line, respectively. The different responses could be related
to how the question was phrased and the mode of admin-
istration. The rate of protocol implementation reported in
our survey is similar to rates that have been reported in
other countries, including Australia (54 %) [18], Germany
(52 %) [8] and the United States (64 %) [19].
The RASS [12] is recommended [1] as one of the most
valid and reliable subjective sedation scales for measur-
ing depth of sedation [20]. The reported use of this sed-
ation scale has increased considerably in the UK since
2007 [3], from 5 % to 65 % of units, with a general shift
away from using the RSS [13]; a quarter of units re-
ported using this scale/score, compared with 67 % in
2007 [3].
The practice of daily sedation holds is recommended
[1, 15, 21] and has been incorporated into the ventilator
care bundle in the UK [22]. The benefits of minimising
sedation include less time on a mechanical ventilator,
fewer complications and reduced length of stay in crit-
ical care [23–25]. The proportion of UK units that re-
ported practicing daily sedation holds was higher (94 %)
than previously reported in 2007 (78 %) [3] and more re-
cently in 2014 (80 %) [16]. Data derived from the PPS
suggest that overall compliance is possibly much lower.
Of the patients who had been in the unit for at least
24 h, around half (53 %) had been considered for a sed-
ation hold in the previous 24 h, and of these, 77 % had
their sedation withheld.
Previous surveys in the UK [2, 3, 16] and elsewhere [4]
indicate a shift from benzodiazepines to propofol for
sedating patients. Both the survey and the PPS indicated
that propofol is by far the most widely used sedative
agent in the UK. Although around one-third of units re-
ported using midazolam, very few reported it to be their
first choice. Use of the alpha-2 agonist clonidine has
Table 4 Reported versus actual sedation scale/score use
Point prevalence study Sedation scale/score reported in national survey
Richmond Agitation-Sedation Scale Ramsay Sedation Scale Riker Sedation-Agitation Scale
Patients who received any sedative/analgesic agenta, n 149 56 12
Sedation scale/score used, n (%)
Assessed with reported scale/score 114 (76.5) 27 (48.2) 11 (91.7)
Assessed with different scale/score 26 (17.4) 10 (17.9) 0 (0)
Not assessed with a scale/score 9 (6.0) 19 (33.9) 1 (8.3)
Percentage of patients assessed with reported
scale/score across unitsb, median (IQR)
88 (63–100)
a Sedated patients in units that participated in the point prevalence study and reported using the indicated sedation scale/score
b Excluding units with fewer than three eligible patients (n = 20)
Table 5 Reported versus actual sedative and analgesic agent use
Point prevalence study First-choice sedative agent reported in national survey
Propofol Midazolam
Patients who received any sedative agenta, n 170 18
Patients who received unit’s first-choice sedative agent, n (%) 149 (87.6) 6 (33.3)
Percentage of patients who received first-choice sedative across unitsb, median (IQR) 100 (64–100)
Point prevalence study First-choice analgesic agent reported in national surveyc
Alfentanil Fentanyl Remifentanil Morphine
Patients who received any analgesic agentd, n 75 61 22 28
Patients who received unit’s first-choice analgesic agent, n (%) 58 (77.3) 57 (93.4) 12 (54.5) 15 (53.4)
Percentage of patients who received first-choice analgesic across unitse, median (IQR) 80 (67–100)
a In critical care units reporting in the national survey that they use the indicated sedative agent as their first choice
b Excluding units with fewer than three eligible patients (n = 23)
c Ten patients in two units that reported using two alternative analgesic agents as their first choice are excluded from data for individual agents but included in
summary data across units (where either of the two indicated agents may have been used)
d In critical care units reporting in the national survey that they use the indicated analgesic agent as their first choice
e Excluding units with fewer than three eligible patients (n = 19)
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increased in the UK, with around one-third of units
reporting very frequent/frequent use, whereas use of
dexmedetomidine is rare. It seems that uptake of dexme-
detomidine in UK critical care has been slow since it
was licensed for use in 2011. Cost may be a factor, with
clinicians preferring to use established and often cheaper
alternatives.
Intravenous opioids are recommended as first-line
agents for non-neuropathic pain in critically ill patients.
Authors of previous UK surveys [2, 3] have reported that
alfentanil, fentanyl and morphine are the most fre-
quently used opioids. Our findings are similar, although
both the survey and the PPS suggest a trend away from
morphine toward agents such as alfentanil and fentanyl
as the first choice for analgesia. Authors of surveys done
elsewhere have reported a similar trend, although mor-
phine is still widely used [4]. Even so, authors of a recent
survey of UK critical care pharmacists reported mor-
phine to be the most common first-line prescription in
almost half (49 %) of units [16].
Surveys are frequently used for establishing current
clinical practice in a variety of healthcare settings, their
advantage being that they are relatively cheap, quick and
simple to conduct, although achieving high response
rates can be challenging. A high response rate (91 %)
was achieved in our survey, comparing favourably with
some previous UK surveys with response rates of 79 %
[2], 64 % [3], 78 % [17] and 60 % [16]. Elsewhere, re-
sponse rates have ranged from 20 % [9] to 84 % [7]. One
limitation of surveys, however, is that reported practice
does not necessarily reflect the reality of actual clinical
practice at the patient level. A major strength of the
present study is the combination of a national survey of
adult general critical care units and a PPS, which en-
abled us to examine both reported sedation practice
across the UK and actual practice at the patient level in
a representative sample of UK units. We were unable to
investigate the reasons for the discrepancies observed
between reported practice and actual practice because of
limited resources for the study. However, it is likely that
these reasons are multifactorial. For example, there may
be a lag between a unit policy being initiated and staff at
the bedside changing their clinical practice, or the dis-
crepancy may reflect the difficulties in applying universal
policies on sedation and analgesia to individual patients,
such as that the choice of agent depends on a number of
individual patient factors. Another possible explanation
is that the person completing the survey is influenced by
her own practice when reporting unit practice, which
may not necessarily reflect that of her colleagues or may
not even be in line with the unit policy. Our results indi-
cate a need for improved auditing of clinical practice
within units to ensure that agreed unit policy on clinical
practice is being followed and, if not, to identify the
reasons. Less than half of units reported in the survey
that they audit compliance with policies, such as sed-
ation holds, and among those that did, there was consid-
erable variability in compliance with unit policy.
A possible limitation of the present study is that the
PPS and the survey were not conducted contemporan-
eously. However, both were completed within a 5-month
period, and it seems unlikely that during this time there
were any major changes in policy within units that might
explain the discrepancies in clinical practice observed.
Furthermore, a potential strength of not conducting the
two studies contemporaneously is that the PPS provided
a snapshot of actual clinical practice before units were
asked about their clinical practice in the survey. Nesting
the PPS within the CMP allowed us to conduct a de-
tailed examination of case mix and outcomes of patients
who were in a CMP unit on the day of the study. Patient
populations in CMP units that did and did not partici-
pate in the PPS were very similar with respect to case
mix and outcomes. Furthermore, comparison of the sur-
vey data from 51 units that participated in the PPS with
all other responding units did not reveal any differences
in reported sedation practices, suggesting that units that
participated in the PPS were a representative sample.
A PPS is relatively quick and simple to conduct. How-
ever, a limitation is that it will only provide a snapshot
of clinical practice at a single point in time. It is also
more likely to capture those patients who stay longer in
the critical care unit. Sedation and analgesia regimens
will vary according to the expected duration of sedation
and analgesia, which is an important factor in determin-
ing the choice of agents.
Conclusions
This study demonstrates that clinical practice reported
in the national survey did not accurately reflect actual
clinical practice at the patient level. Employing a mixed
methods approach provided a more complete picture of
current sedation practice in UK critical care in terms of
the breadth and the depth of information.
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